Impact of Prescription Drug Diversion Control Systems on Medical Practice and Patient Care: NIDA Research Monograph 131

1993 ◽  
Author(s):  
James R. Cooper ◽  
◽  
Dorynne J. Czechowicz ◽  
Stephen P. Molinari ◽  
Robert C. Peterson
Keyword(s):  
Patient Care ◽  
Prescription Drug ◽  
Control Systems ◽  
Medical Practice ◽  
Drug Diversion

Prescription drug diversion control and medical practice

JAMA ◽  
1992 ◽  
Vol 268 (10) ◽  
pp. 1306-1310 ◽  
Author(s):  
J. R. Cooper
Keyword(s):  
Prescription Drug ◽  
Medical Practice ◽  
Drug Diversion

Summary and Conclusions of a Review of Prescription Drug Diversion Control Methods

1993 ◽  
Author(s):  
Constance Horgan ◽  
◽  
Jeffrey Prottas ◽  
Christopher Tompkins ◽  
Linda Wastila ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Control Methods ◽  
Drug Diversion

Integral Metatheory in the Time of COVID: Implications for Medical and Nursing Teaching and Practice

2021 ◽  
pp. HumanCaring-D-20-00027
Author(s):  
Stephen J. Darcy
Keyword(s):  
Nursing Education ◽  
Clinical Practice ◽  
Patient Care ◽  
Medical Practice ◽  
Potential Application ◽  
Illness Experience ◽  
Comprehensive View ◽  
Practice Of Medicine ◽  
Basic Concepts ◽  
Interpretive Framework

Ken Wilber's integral metatheory is an interpretive framework that can that be applied to the clinical practice of medicine and medical and nursing education. It offers a comprehensive view of the patient illness experience superior to current models of patient care and may provide a valuable guide for nursing and medical practice and teaching. This article seeks to explain some of the basic concepts of integral metatheory and show their potential application to practice and teaching using the current COVID-19 pandemic as an illustrative model.

Whatever Happened to the Decade of Pain Control and Research?

2018 ◽  
Author(s):  
John J. Coleman
Keyword(s):  
United States ◽  
Chronic Pain ◽  
Drug Abuse ◽  
Prescription Drug ◽  
Pain Control ◽  
The United States ◽  
Prescription Drug Abuse ◽  
Policy Changes ◽  
Felony Conviction ◽  
Drug Diversion

This chapter discusses how the pharmaceutical industry’s actions affected the accomplishments of the Decade of Pain Control and Research, which began on January 1, 2001, following almost two decades of rising concern over the inadequate treatment of chronic pain in the United States. To tell the story of this decade we must describe the accompanying problem of drug diversion and abuse. The development in 1995 of a new opioid product called OxyContin, its aggressive marketing, the morbidity and mortality associated with its misuse, and the eventual felony conviction in 2007 of the drug’s sponsor for fraudulent claims and marketing practices, affected the Decade in unexpected ways. The response by Congress and the regulatory community to what they termed an “epidemic” of prescription drug abuse produced long-lasting policy changes. The chapter also touches on the peculiar and sometimes troubling relationship between the regulators and the regulated.

scholarly journals The “Black Box” of Prescription Drug Diversion

2009 ◽  
Vol 28 (4) ◽  
pp. 332-347 ◽  
Author(s):  
James A. Inciardi ◽  
Hilary L. Surratt ◽  
Theodore J. Cicero ◽  
Steven P. Kurtz ◽  
Steven S. Martin ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Black Box ◽  
Drug Diversion
Sign in / Sign up

Export Citation Format

Share Document